+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Reproductive Technologies Market by Assisted Reproductive Technology Type, Application, Fertility Drug Type, Service Provider, End User - Global Forecast to 2030- Product Image
Human Reproductive Technologies Market by Assisted Reproductive Technology Type, Application, Fertility Drug Type, Service Provider, End User - Global Forecast to 2030- Product Image
Sale

Human Reproductive Technologies Market by Assisted Reproductive Technology Type, Application, Fertility Drug Type, Service Provider, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5887220
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Human Reproductive Technologies Market is rapidly evolving, driven by new advancements addressing rising infertility rates and changing patient needs. Senior stakeholders must understand this complex, technology-enabled landscape to make informed decisions and capitalize on emerging opportunities.

Market Snapshot: Human Reproductive Technologies Market

The Human Reproductive Technologies Market grew from USD 31.82 billion in 2024 to USD 33.97 billion in 2025. It is expected to continue growing at a CAGR of 6.68%, reaching USD 46.92 billion by 2030. Strong demand is being driven by precision medicine, advanced diagnostics, and shifting demographics. This market is characterized by the adoption of next-generation genetic testing, enhanced fertility therapeutics, and robust digital integration throughout the patient journey. As providers seek differentiated offerings, technology-driven fertility solutions are extending treatment windows, optimizing outcomes, and improving accessibility worldwide.

Scope & Segmentation

  • Assisted Reproductive Technology Types: Gamete intrafallopian transfer, in vitro fertilization (fresh embryo transfer, frozen embryo transfer), intracytoplasmic sperm injection, intrauterine insemination, zygote intrafallopian transfer
  • Applications: Fertility preservation (embryo, oocyte, and sperm cryopreservation), genetic testing (PGT-A, PGT-M, PGT-SR), infertility treatment
  • Fertility Drug Types: GnRH analogue, gonadotropin, human chorionic gonadotropin, progesterone
  • Service Providers: Fertility clinics, hospitals, research institutes
  • End Users: Heterosexual couples, LGBTQ couples, single parents
  • Regions Covered: Americas (including U.S. states such as California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; plus Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies Profiled: Merck KGaA, Ferring Pharmaceuticals A/S, Progyny, Inc., Vitrolife AB, Cook Medical LLC, CooperSurgical, Inc., Natera, Inc., Illumina, Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc.

Key Takeaways for Senior Decision-Makers

  • Clinics and providers are integrating AI-driven embryo selection and noninvasive genetic screening to improve clinical success and patient experience.
  • Digital solutions, such as telehealth and real-time hormone monitoring, support adherence, remote consultation, and data-driven protocol refinements.
  • Frozen embryo transfer is outperforming other protocols in terms of growth, attributed to flexibility and advances in endometrial synchrony management.
  • Demand for fertility preservation is increasing, especially among diverse patient populations, fueled by elective family planning and referrals from oncology.
  • Manufacturers and suppliers are investing in local capacity and strategic partnerships to reduce supply chain risk and adapt to market pressures.
  • Product strategies tailored by patient demographic, clinical need, and reimbursement environment deliver differentiated competitive positioning.

Tariff Impact on Human Reproductive Technologies Market

The introduction of new U.S. tariff measures has raised operational costs for reproductive technology providers by increasing prices on imported laboratory reagents, devices, and pharmaceutical ingredients. This has triggered shifts in procurement, local manufacturing investments, and supply chain realignment. Stakeholders are responding by adopting long-term supply contracts, exploring regional partnerships, and advancing digital service differentiation to maintain competitiveness in a more protectionist trade environment.

Methodology & Data Sources

This analysis integrates extensive primary interviews with clinicians, laboratory directors, and regulatory specialists, and secondary sources such as scientific publications, industry databases, and company reports. A dual top-down and bottom-up approach ensures both macro- and micro-level drivers are accurately assessed, validated through data triangulation, expert peer review, and cross-verification with historical performance trends.

Why This Report Matters

  • Enables leaders to benchmark strategies against industry innovators, adapt to regulatory and policy changes, and capture emerging demand in key segments.
  • Provides reliable, actionable intelligence to support investment decisions, operational planning, and new product or service launches.
  • Delivers structured segmentation and regional analysis essential for tailoring offerings to maximize impact in diverse healthcare environments.

Conclusion

Sustainable growth in the human reproductive technologies market requires holistic strategies, from precision technology adoption to regional and patient-centric customization. Senior decision-makers equipped with these insights can navigate complexity, drive innovation, and secure long-term positioning in this dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Human Reproductive Technologies Market, by Assisted Reproductive Technology Type
8.1. Introduction
8.2. Gamete Intrafallopian Transfer
8.3. in Vitro Fertilization
8.3.1. Fresh Embryo Transfer
8.3.2. Frozen Embryo Transfer
8.4. Intracytoplasmic Sperm Injection
8.5. Intrauterine Insemination
8.6. Zygote Intrafallopian Transfer
9. Human Reproductive Technologies Market, by Application
9.1. Introduction
9.2. Fertility Preservation
9.2.1. Embryo Cryopreservation
9.2.2. Oocyte Cryopreservation
9.2.3. Sperm Cryopreservation
9.3. Genetic Testing
9.3.1. PGT a
9.3.2. PGT M
9.3.3. PGT SR
9.4. Infertility Treatment
10. Human Reproductive Technologies Market, by Fertility Drug Type
10.1. Introduction
10.2. GnRH Analogue
10.3. Gonadotropin
10.4. Human Chorionic Gonadotropin
10.5. Progesterone
11. Human Reproductive Technologies Market, by Service Provider
11.1. Introduction
11.2. Fertility Clinic
11.3. Hospital
11.4. Research Institute
12. Human Reproductive Technologies Market, by End User
12.1. Introduction
12.2. Heterosexual Couple
12.3. LGBTQ Couple
12.4. Single Parent
13. Americas Human Reproductive Technologies Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Human Reproductive Technologies Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Human Reproductive Technologies Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Merck KGaA
16.3.2. Ferring Pharmaceuticals a/S
16.3.3. Progyny, Inc.
16.3.4. Vitrolife AB
16.3.5. Cook Medical LLC
16.3.6. CooperSurgical, Inc.
16.3.7. Natera, Inc.
16.3.8. Illumina, Inc.
16.3.9. Laboratory Corporation of America Holdings
16.3.10. Thermo Fisher Scientific Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET MULTI-CURRENCY
FIGURE 2. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET MULTI-LANGUAGE
FIGURE 3. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FRESH EMBRYO TRANSFER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FROZEN EMBRYO TRANSFER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ZYGOTE INTRAFALLOPIAN TRANSFER, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY EMBRYO CRYOPRESERVATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY OOCYTE CRYOPRESERVATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SPERM CRYOPRESERVATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PGT A, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PGT M, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PGT SR, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INFERTILITY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GNRH ANALOGUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GONADOTROPIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY HUMAN CHORIONIC GONADOTROPIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PROGESTERONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY HETEROSEXUAL COUPLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY LGBTQ COUPLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SINGLE PARENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 59. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 60. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 62. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 63. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 64. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 65. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 67. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 68. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 70. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 71. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 72. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 73. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 108. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 109. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 111. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 112. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 113. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 114. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 116. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 117. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 119. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 120. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 121. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 122. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 132. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 133. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 135. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 136. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 137. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 138. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 140. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 141. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 143. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 144. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 145. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 146. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. DENMARK HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 172. DENMARK HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 173. DENMARK HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. DENMARK HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 175. DENMARK HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 176. DENMARK HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 177. DENMARK HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 178. DENMARK HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 186. NETHERLANDS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. QATAR HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 188. QATAR HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 189. QATAR HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. QATAR HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 191. QATAR HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 192. QATAR HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 193. QATAR HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 194. QATAR HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. FINLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 196. FINLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 197. FINLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. FINLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 199. FINLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 200. FINLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 201. FINLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 202. FINLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 218. NIGERIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. EGYPT HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 220. EGYPT HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 221. EGYPT HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. EGYPT HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 223. EGYPT HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 224. EGYPT HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 225. EGYPT HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 226. EGYPT HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. TURKEY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 228. TURKEY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 229. TURKEY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. TURKEY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 231. TURKEY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 232. TURKEY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 233. TURKEY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 234. TURKEY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. NORWAY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 244. NORWAY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 245. NORWAY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. NORWAY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 247. NORWAY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 248. NORWAY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 249. NORWAY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 250. NORWAY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. POLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 252. POLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 253. POLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. POLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 255. POLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 256. POLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 257. POLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 258. POLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 276. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 277. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 278. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 280. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 281. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 282. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 283. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. INDIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 285. INDIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 286. INDIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. INDIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, 2018-2030 (USD MILLION)
TABLE 288. INDIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 289. INDIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 290. INDIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SERVICE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Human Reproductive Technologies market report include:
  • Merck KGaA
  • Ferring Pharmaceuticals A/S
  • Progyny, Inc.
  • Vitrolife AB
  • Cook Medical LLC
  • CooperSurgical, Inc.
  • Natera, Inc.
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 33.97 Billion
Forecasted Market Value ( USD ) by 2030 $ 46.92 Billion
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Assisted Reproductive Technology Market by Technique, Cycle Type, Treatment, End User, Product - Global Forecast to 2030 - Product Image

Assisted Reproductive Technology Market by Technique, Cycle Type, Treatment, End User, Product - Global Forecast to 2030

  • Report
  • 187 Pages
  • Global
From
Assisted Reproductive Technology - Global Strategic Business Report - Product Image

Assisted Reproductive Technology - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Assisted Reproductive Technology Market by Technology (in Vitro Fertilization, Artificial Insemination), Type (Instruments (Incubators), Media (Cryopreservation), Supplements, Consumables), Patient Type (Male, Female), End User - Global Forecast to 2030 - Product Image

Assisted Reproductive Technology Market by Technology (in Vitro Fertilization, Artificial Insemination), Type (Instruments (Incubators), Media (Cryopreservation), Supplements, Consumables), Patient Type (Male, Female), End User - Global Forecast to 2030

  • Report
  • 321 Pages
  • Global
From
Human Reproductive Technologies - Global Strategic Business Report - Product Image

Human Reproductive Technologies - Global Strategic Business Report

  • Report
  • 167 Pages
  • Global
From
Assisted Reproductive Technology Market Report 2025 - Product Image

Assisted Reproductive Technology Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Human Reproductive Technologies Market

The Human Reproductive Technologies market is a subset of the Sexual and Reproductive Health Drugs market. It includes products and services related to fertility, contraception, and assisted reproductive technologies. These technologies are used to help individuals and couples conceive, prevent pregnancy, and manage reproductive health. They include fertility treatments such as in vitro fertilization (IVF), intrauterine insemination (IUI), and ovulation induction, as well as contraception methods such as birth control pills, intrauterine devices (IUDs), and male and female condoms. Assisted reproductive technologies include egg and sperm donation, surrogacy, and preimplantation genetic diagnosis (PGD). Some companies in the Human Reproductive Technologies market include Ferring Pharmaceuticals, Merck, Bayer, and CooperSurgical. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.